Navigation Links
Turning human stem cells into brain cells sheds light on neural development
Date:5/2/2013

Medical researchers have manipulated human stem cells into producing types of brain cells known to play important roles in neurodevelopmental disorders such as epilepsy, schizophrenia and autism. The new model cell system allows neuroscientists to investigate normal brain development, as well as to identify specific disruptions in biological signals that may contribute to neuropsychiatric diseases.

Scientists from The Children's Hospital of Philadelphia and the Sloan-Kettering Institute for Cancer Research led a study team that described their research in the journal Cell Stem Cell, published online today.

The research harnesses human embryonic stem cells (hESCs), which differentiate into a broad range of different cell types. In the current study, the scientists directed the stem cells into becoming cortical interneuronsa class of brain cells that, by releasing the neurotransmitter GABA, controls electrical firing in brain circuits.

"Interneurons act like an orchestra conductor, directing other excitatory brain cells to fire in synchrony," said study co-leader Stewart A. Anderson, M.D., a research psychiatrist at The Children's Hospital of Philadelphia. "However, when interneurons malfunction, the synchrony is disrupted, and seizures or mental disorders can result."

Anderson and study co-leader Lorenz Studer, M.D., of the Center for Stem Cell Biology at Sloan-Kettering, derived interneurons in a laboratory model that simulates how neurons normally develop in the human forebrain.

"Unlike, say, liver diseases, in which researchers can biopsy a section of a patient's liver, neuroscientists cannot biopsy a living patient's brain tissue," said Anderson. Hence it is important to produce a cell culture model of brain tissue for studying neurological diseases. Significantly, the human-derived cells in the current study also "wire up" in circuits with other types of brain cells taken from mice, when cultured together. Those interactions, Anderson added, allowed the study team to observe cell-to-cell signaling that occurs during forebrain development.

In ongoing studies, Anderson explained, he and colleagues are using their cell model to better define molecular events that occur during brain development. By selectively manipulating genes in the interneurons, the researchers seek to better understand how gene abnormalities may disrupt brain circuitry and give rise to particular diseases. Ultimately, those studies could help inform drug development by identifying molecules that could offer therapeutic targets for more effective treatments of neuropsychiatric diseases.

In addition, Anderson's laboratory is studying interneurons derived from stem cells made from skin samples of patients with chromosome 22q.11.2 deletion syndrome, a genetic disease which has long been studied at The Children's Hospital of Philadelphia. In this multisystem disorder, about one third of patients have autistic spectrum disorders, and a partially overlapping third of patients develop schizophrenia. Investigating the roles of genes and signaling pathways in their model cells may reveal specific genes that are crucial in those patients with this syndrome who have neurodevelopmental problems.


'/>"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert

Related biology news :

1. Returning military personnel to duty following severe injury to the lower extremity
2. Researchers find molecular switch turning on self-renewal of liver damage
3. AZTI-Tecnalia is turning vegetable by-products destined for landfills into feedstuff
4. Zebrafish may hold the answer to repairing damaged retinas and returning eyesight to people
5. Why astronauts experience low blood pressure after returning to Earth from space
6. Turning ideas into products faster
7. Turning down the dial: Ocean energy development with less sound
8. Turning off small RNA
9. OGIs investment in cytognomix contributes to the Shannon Human Splicing Pipelines success
10. CNIO researchers capture the replication of the human genome for the first time
11. Source identification of H7N9 influenza virus causing human infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com , ... biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European Hematology ... Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase 1 ...
(Date:7/1/2020)... VENICE, Calif. (PRWEB) , ... July 01, 2020 ... ... focused on building awareness and solutions for glioblastoma—the most common and aggressive adult ... and Lisa Haile, JD, PhD. Senior Fellows are charged with supporting the organization’s ...
(Date:6/25/2020)... ... 2020 , ... eClinical Solutions LLC , a leading ... drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ) on randomized ... COVID-19. This is the first study of an XPO1 inhibitor in patients with ...
Breaking Biology News(10 mins):
(Date:6/3/2020)... ... June 03, 2020 , ... Thought ... of biofeedback. In the next installment, Dr. Inna Khazan will discuss the benefits ... to bring their attention to the feelings, thoughts, and emotions they are having ...
(Date:5/30/2020)... ... May 29, 2020 , ... The Conference Forum is ... solely dedicated to the unique role of the Chief Medical Officer in the ... responsibilities, problem-solving, best practices and career development of CMOs and Heads of R&D ...
(Date:5/26/2020)... ... May 26, 2020 , ... Brilliant , the leading smart home ... garage door openers, announce a new integration to bring more convenience, simplicity, and security ... powered by Aladdin Connect® can now be controlled from Brilliant’s in-wall touchscreen control panels ...
(Date:5/21/2020)... ... May 19, 2020 , ... Eaton Square is pleased to announce ... and Company, a biotechnology and medical technology-focused strategy and M&A advisory firm. , This ... United States, linking US and Asia Pacific healthcare innovators with capital and investors. , ...
Breaking Biology Technology: